Neurological development of children who are HIV‐exposed and uninfected
Open Access
- 14 May 2021
- journal article
- review article
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 63 (10) , 1161-1170
Abstract
Widespread use of antiretroviral drugs for pregnant/breastfeeding females with human immunodeficiency virus (HIV) has led to declining vertical transmission. Despite being HIV‐uninfected, the increasing number of children who are HIV‐exposed and uninfected (CHEU) often present with developmental alterations. We review seminal and recent evidence on the neurological development of CHEU and associations with early life HIV/antiretroviral exposure. Our conceptual model highlights the numerous exposures and universal risk factors for CHEU developmental disorders. Early studies suggest a significant association between HIV exposure and neurological abnormalities, varying according to the burden of HIV‐specific exposures and other risk factors. More recent observations from the modern era are inconsistent, although some studies suggest specific antiretrovirals may adversely affect neurological development of CHEU. As the CHEU population continues to grow, alongside simultaneous increases in types and combinations of antiretrovirals used in pregnancy, long‐term monitoring of CHEU is necessary for understanding the effects of HIV/antiretroviral exposure on CHEU developmental outcomes. What this paper adds: Evidence on the neurological development of children who are human immunodeficiency virus (HIV)‐exposed and uninfected (CHEU) is synthesized. Comparisons are made to children who are HIV‐unexposed, across treatment eras and settings, and by antiretroviral drug regimens and drug classes. CHEU exposures are complex and include HIV‐specific and universal risk factors which may affect development during the early years of life.Keywords
This publication has 110 references indexed in Scilit:
- Persistent household food insecurity, HIV, and maternal stress in Peri-Urban GhanaBMC Public Health, 2013
- Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in ZambiaClinical Infectious Diseases, 2012
- Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trialThe Lancet, 2012
- Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During PregnancyThe Journal of Infectious Diseases, 2011
- Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutationsNature Genetics, 2011
- Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 TransmissionNew England Journal of Medicine, 2010
- Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational StudiesAmerican Journal of Psychiatry, 2010
- Neurodevelopment and In Utero Antiretroviral Exposure of HIV-Exposed Uninfected InfantsPediatrics, 2010
- Impact of the HIV/AIDS Epidemic on the Neurodevelopment of Preschool-Aged Children in Kinshasa, Democratic Republic of the CongoPediatrics, 2008
- Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondria in Human Immunodeficiency Virus Type 1-Infected Children Receiving Highly Active Antiretroviral TherapyAntimicrobial Agents and Chemotherapy, 2007